# Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure

> **NCT07656168** · NA · RECRUITING · sponsor: **China-Japan Friendship Hospital** · enrollment: 100 (estimated)

## Conditions studied

- ESRD (End-Stage Renal Disease)
- Maintenance Hemodialysis

## Interventions

- **DEVICE:** pHA130 Hemoadsorption Cartridge
- **DEVICE:** High-flux Hemodialyzer

## Key facts

- **NCT ID:** NCT07656168
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-04
- **Final completion:** 2028-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07656168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07656168, "Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07656168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*